Mark Eggink

Mark Eggink

Company: Byondis

Job title: Principal Scientist

Seminars:

Panel Discussion – Can Analytical Development be Platformed? 11:30 am

Discussing the feasibility of platforming analytical methods across a range of ADCs Is platforming analytical methods applicable to novel-payload ADCs? How can clinical and CMC stability data feed into early development, and alter the platform for improved therapeutic outcomes?Read more

day: Day Two

One Size Fits All? Compiling a Panel of Platform Analytical Methods For Antibodies & Antibody-Drug Conjugates 11:00 am

Based on prior knowledge, a set of platform physiochemical methods was assembled, consistent with the principles of AQbD Understand how the methods are suited for release and stability testing, in addition to aiding process development of monoclonal antibodies and antibody-drug conjugates The platform methods are intended to support the accelerated early development (up to and…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.